Upside – $PROF +19% (preliminary Q3 revenue was about 45%-47% above consensus, with gross margin expected above 70%) – $HAE +14% (no fresh company catalyst confirmed; unusually large move on light premarket volume) – $WOLF +13% (received a conditional commitment for up to $1.5B of 30-year U.S. defense financing, partly offset by warrants for up …
Read in context ›Lam Research Stock (LRCX)
Track Lam Research stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
LRCX
Lam Research
technology
At close
$318.84
▼ -1.75 (-0.55%)
Oct 9, 4:00 PM ET
After-hours
$318.80
▼ -0.04 (-0.01%)
Oct 9, 7:59 PM ET
Market Cap
$401.19B
P/E Ratio
55.0x
1Y Return
+125.96%
EPS (TTM)
$5.76
Read the latest TheStreet Pro articles mentioning Lam Research, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
92 articlesDaily Diary Mentions
3 mentionsUpside, Downside Movers in the Morning Upside, Downside Movers in the Morning Upside – $LPCN +40% (Health Canada approves TLANDO for testosterone replacement therapy) – $APUS +9.4% (extends a high-volume rally tied to the BlockAssure agreement to build and operate the AssureChain insurance network) – $PENG +4.3% (Q4 beat and FY27 sales and EPS outlook topped prior guidance and Street expectations on accelerating AI-infrastructure demand) – CNQ …
Read in context ›That's a Wrap What a week it was. On Tuesday, the Conference Board told us that U.S. consumers were in a state of outright despair. On Friday, the University of Michigan told us that U.S. consumers are actually doing better. On Thursd…
Read in context ›